AAAAAA

   
Results: 1-14 |
Results: 14
WHAT THRESHOLD FOR ADJUVANT TAMOXIFEN IN OLDER BREAST-CANCER PATIENTS- A DECISION-ANALYSIS
Authors: EXTERMANN M BALDUCCI L LYMAN G
Citation: M. Extermann et al., WHAT THRESHOLD FOR ADJUVANT TAMOXIFEN IN OLDER BREAST-CANCER PATIENTS- A DECISION-ANALYSIS, European journal of cancer, 34, 1998, pp. 103-103
MEASUREMENT OF COMORBIDITY IN THE OLDER CANCER-PATIENT
Authors: EXTERMANN M
Citation: M. Extermann, MEASUREMENT OF COMORBIDITY IN THE OLDER CANCER-PATIENT, Annals of oncology, 9, 1998, pp. 26-26
UNDERSTANDING THE COMPREHENSIVE-GERIATRIC-ASSESSMENT (CGA) IMPACT ON SURVIVAL AND TIME TO DISEASE PROGRESSION IN OLDER CANCER-PATIENTS
Authors: OVERCASH J CHEN H EXTERMANN M CANTOR A BALDUCCI L
Citation: J. Overcash et al., UNDERSTANDING THE COMPREHENSIVE-GERIATRIC-ASSESSMENT (CGA) IMPACT ON SURVIVAL AND TIME TO DISEASE PROGRESSION IN OLDER CANCER-PATIENTS, Annals of oncology, 9, 1998, pp. 45-45
WHAT THRESHOLD FOR ADJUVANT THERAPY IN OLDER BREAST-CANCER PATIENTS
Authors: EXTERMANN M BALDUCCI L LYMAN GH
Citation: M. Extermann et al., WHAT THRESHOLD FOR ADJUVANT THERAPY IN OLDER BREAST-CANCER PATIENTS, Annals of oncology, 9, 1998, pp. 96-96
COMORBIDITY AND FUNCTIONAL STATUS ARE INDEPENDENT IN OLDER CANCER-PATIENTS
Authors: EXTERMANN M OVERCASH J LYMAN GH PARR J BALDUCCI L
Citation: M. Extermann et al., COMORBIDITY AND FUNCTIONAL STATUS ARE INDEPENDENT IN OLDER CANCER-PATIENTS, Journal of clinical oncology, 16(4), 1998, pp. 1582-1587
RELATIONSHIP BETWEEN CLEAVED L-SELECTIN LEVELS AND THE OUTCOME OF ACUTE MYELOID-LEUKEMIA
Authors: EXTERMANN M BACCHI M MONAI N FOPP M FEY M TICHELLI A SCHAPIRA M SPERTINI O
Citation: M. Extermann et al., RELATIONSHIP BETWEEN CLEAVED L-SELECTIN LEVELS AND THE OUTCOME OF ACUTE MYELOID-LEUKEMIA, Blood, 92(9), 1998, pp. 3115-3122
SHOULD ADJUVANT CHEMOTHERAPY BE USED TO TREAT BREAST-CANCER IN ELDERLY PATIENTS (GREATER-THAN-OR-EQUAL-TO-70 YEARS OF AGE)
Authors: BALDUCCI L EXTERMANN M FENTIMAN I MONFARDINI S PERRONE F
Citation: L. Balducci et al., SHOULD ADJUVANT CHEMOTHERAPY BE USED TO TREAT BREAST-CANCER IN ELDERLY PATIENTS (GREATER-THAN-OR-EQUAL-TO-70 YEARS OF AGE), European journal of cancer, 33(11), 1997, pp. 1720-1722
ACUTE-LEUKEMIA IN THE ELDERLY
Authors: EXTERMANN M
Citation: M. Extermann, ACUTE-LEUKEMIA IN THE ELDERLY, Clinics in geriatric medicine, 13(2), 1997, pp. 227
CANCER-CHEMOTHERAPY IN THE OLDER PATIENT - WHAT THE MEDICAL ONCOLOGIST NEEDS TO KNOW
Authors: BALDUCCI L EXTERMANN M
Citation: L. Balducci et M. Extermann, CANCER-CHEMOTHERAPY IN THE OLDER PATIENT - WHAT THE MEDICAL ONCOLOGIST NEEDS TO KNOW, Cancer, 80(7), 1997, pp. 1317-1322
COST REDUCTIVE USE OF ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASIA
Authors: PATTERSON SG BENSON K BALDUCCI L EXTERMANN M LYMAN GH LEE H
Citation: Sg. Patterson et al., COST REDUCTIVE USE OF ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASIA, Blood, 90(10), 1997, pp. 3324-3324
RADIATION RECALL IN A PATIENT WITH BREAST-CANCER TREATED FOR TUBERCULOSIS
Authors: EXTERMANN M VOGT N FORNI M DAYER P
Citation: M. Extermann et al., RADIATION RECALL IN A PATIENT WITH BREAST-CANCER TREATED FOR TUBERCULOSIS, European Journal of Clinical Pharmacology, 48(1), 1995, pp. 77-78
INITIAL TREATMENT OF SEPSIS IN NON-NEUTROPENIC PATIENTS - CEFTAZIDIMEALONE VERSUS BEST GUESS COMBINED ANTIBIOTIC-THERAPY
Authors: EXTERMANN M REGAMEY C HUMAIR L MURISIER F RHYNER K VONWILLER HM
Citation: M. Extermann et al., INITIAL TREATMENT OF SEPSIS IN NON-NEUTROPENIC PATIENTS - CEFTAZIDIMEALONE VERSUS BEST GUESS COMBINED ANTIBIOTIC-THERAPY, Chemotherapy, 41(4), 1995, pp. 306-315
TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN A PATIENT TREATEDWITH CLADRIBINE (2-CHLORODEOXYADENOSINE) - DEMONSTRATION OF EXOGENOUSDNA IN VARIOUS TISSUE-EXTRACTS BY PCR ANALYSIS
Authors: ZULIAN GB ROUX E TIERCY JM EXTERMANN M DIEBOLDBERGER S REYMOND JM HELG C ZUBLER R BETTICHER DC ALBERTO P JEANNET M CHAPUIS B
Citation: Gb. Zulian et al., TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN A PATIENT TREATEDWITH CLADRIBINE (2-CHLORODEOXYADENOSINE) - DEMONSTRATION OF EXOGENOUSDNA IN VARIOUS TISSUE-EXTRACTS BY PCR ANALYSIS, British Journal of Haematology, 89(1), 1995, pp. 83-89
EMPIRICAL ANTIBIOTIC-TREATMENT OF SEPSIS IN NON-NEUTROPENIC PATIENTS - SINGLE-AGENT OR COMBINATION THERAPY
Authors: EXTERMANN M REGAMEY C
Citation: M. Extermann et C. Regamey, EMPIRICAL ANTIBIOTIC-TREATMENT OF SEPSIS IN NON-NEUTROPENIC PATIENTS - SINGLE-AGENT OR COMBINATION THERAPY, Infection, 22(1), 1994, pp. 1-3
Risultati: 1-14 |